Otzi the Iceman: Researchers validate the stability of genetic markers
Biomarkers are biological attributes that can give doctors or researchers clues about the health status or illnesses of a patient. Scientists are placing great hope in a new type of biomarker, so-called microRNAs. These short ribonucleic acid molecules are notable for their very high level of stability. Researchers at Saarland University, the University of Luxembourg and the Eurac Research center in Bozen have now established that such microRNAs can remain stable even after 5,300 years.
They have found the molecules in the well-known glacier mummy "Ötzi". A number of facts have been scientifically proven about the glacier mummy, known as "the Iceman" or "Ötzi," found in the Ötztal Alps (South Tyrol) in 1991. Through imaging techniques, we know about degeneration in his lumbar spine and a fatal arrow wound in his left shoulder. DNA analyses showed that Ötzi was lactose intolerant, and had brown eyes and blood type 0. Now a study of Ötzi's microRNAs has also been completed. MicroRNAs are very small pieces of ribonucleic acid (RNA) and play a central role in the regulation of genes.
Although these molecules are very stable in tissues, prior to this study it was unclear whether they could still be found in human tissues after thousands of years. Therefore, Professors Andreas Keller and Eckart Meese of Saarland University, Stephanie Kreis of the University of Luxembourg, and Professor Albert Zink and Frank Maixner of Eurac Research in Bozen took on the challenge. They analyzed not only tissue samples from the Iceman, but also those from a mummy of a soldier fallen in World War I. "Our investigation provides evidence that we can analyze microRNA even after thousands of years," explains Andreas Keller, Professor of Clinical Bioinformatics at Saarland University, who coordinated the study.
The scientists took samples from Ötzi's skin, stomach, and stomach contents. "It was a challenge to extract this genetic material in significant quantities and sufficient quality from the mummified tissue samples, and to measure and quantify it with the newest, very precise methods," reports Stephanie Kreis, who isolated the microRNAs at the University of Luxembourg. Some molecules were found that were present predominantly in the ancient tissues. Conversely, some of the biomarkers that are well-known today were not found in Ötzi. According to Professor Zink from Eurac Research, the microRNAs are the next important class of molecules from Ötzi to receive intensive examination.
Professor Meese, head of the Institute of Human Genetics at Saarland University, claims that the stability of these biomarkers is also important for people today. "It is vital for clinical applications," explains Meese. "It's evident that the potential of microRNA is much greater than we previously thought. We still don't know enough about how these molecules influence specific genes, entire gene families, or biochemical reaction pathways. When we investigate this further, it's possible microRNAs will become new stars in therapy. Until then, however, there is a lot more work to do," concludes Professor Keller.